Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2011; 17(19): 2417-2423
Published online May 21, 2011. doi: 10.3748/wjg.v17.i19.2417
Published online May 21, 2011. doi: 10.3748/wjg.v17.i19.2417
Group I (n = 15) | Group II(n = 15) | Group III(n = 15) | |
Age (yr) | 40.3 ± 14.6 | 52.9 ± 17.8 | 65.5 ± 11.2 |
Sex (male/female) | 8/7 | 9/6 | 7/8 |
Disease duration (yr) | ------ | 6 ± 1.1 | 7 ± 2.1 |
TG (mg/dL) | 90.3 ± 14.5 | 92.0 ± 10.8 | 96.5 ± 10.8 |
TC (mg/dL) | 160.5 ± 13.76 | 167.6 ± 15.3 | 170.5 ± 13.8 |
LDL-C (mg/dL) | 124 ± 16.46 | 142.33 ± 24.41 | 142.66 ± 24.33 |
HDL-C (mg/dL) | 54.50 ± 11.81 | 44.06 ± 9.12 | 41.60 ± 10.85 |
Hb (g/dL) | 13.1 ± 1 | 11.78 ± 1.2 | 11.3 ± 0.9 |
WBC (/mm3) | 5180 ± 967 | 5630 ± 1252 | 5033.3 ± 976 |
PLT (104/mm3) | 34.8 ± 5 | 36 ± 4.9 | 38 ±4.2 |
Albumin (g/dL) | 4.1 ± 0.23 | 4.08 ± 0.35 | 2.9 ± 0.29 |
- Citation: Hamouda HE, Zakaria SS, Ismail SA, Khedr MA, Mayah WW. p53 antibodies, metallothioneins, and oxidative stress markers in chronic ulcerative colitis with dysplasia. World J Gastroenterol 2011; 17(19): 2417-2423
- URL: https://www.wjgnet.com/1007-9327/full/v17/i19/2417.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i19.2417